AngioDynamics Foresees New Laser Sales Opportunities With Sotradecol Drug
AngioDynamics expects to expand into hitherto untargeted markets with the help of its newly licensed Sotradecol drug for the treatment of small, uncomplicated varicose veins
AngioDynamics expects to expand into hitherto untargeted markets with the help of its newly licensed Sotradecol drug for the treatment of small, uncomplicated varicose veins